Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.
3.

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.

Faraone SV, Buitelaar J.

Eur Child Adolesc Psychiatry. 2010 Apr;19(4):353-64. doi: 10.1007/s00787-009-0054-3. Epub 2009 Sep 10.

PMID:
19763664
4.

The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.

Heal DJ, Cheetham SC, Smith SL.

Neuropharmacology. 2009 Dec;57(7-8):608-18. doi: 10.1016/j.neuropharm.2009.08.020. Epub 2009 Sep 15. Review.

PMID:
19761781
5.

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.

Wigal SB, Kollins SH, Childress AC, Squires L; 311 Study Group.

Child Adolesc Psychiatry Ment Health. 2009 Jun 9;3(1):17. doi: 10.1186/1753-2000-3-17.

6.

Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.

Newcorn JH, Sutton VK, Weiss MD, Sumner CR.

J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):511-8. doi: 10.1097/CHI.0b013e31819c55b2.

PMID:
19318988
7.

Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.

Pliszka S; AACAP Work Group on Quality Issues.

J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921. Review.

PMID:
17581453
9.

Remission versus response as the goal of therapy in ADHD: a new standard for the field?

Steele M, Jensen PS, Quinn DM.

Clin Ther. 2006 Nov;28(11):1892-908. Review.

PMID:
17213010
10.

The worldwide prevalence of ADHD: is it an American condition?

Faraone SV, Sergeant J, Gillberg C, Biederman J.

World Psychiatry. 2003 Jun;2(2):104-13.

11.

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopez M; Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder.

J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):642-57.

PMID:
16721314
12.

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.

Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E.

Eur Child Adolesc Psychiatry. 2006 Dec;15(8):476-95. Epub 2006 May 5. Review.

PMID:
16680409
13.

A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.

Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE.

Can J Clin Pharmacol. 2006 Winter;13(1):e50-62. Epub 2006 Jan 23.

PMID:
16456216
14.

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD.

Pediatrics. 2001 Jun;107(6):E105.

PMID:
11389303
15.

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, Clevenger W, Davies M, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Owens EB, Pelham WE, Schiller E, Severe JB, Simpson S, Vitiello B, Wells K, Wigal T, Wu M.

J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):168-79.

PMID:
11211365
16.

Quebec child mental health survey: prevalence of DSM-III-R mental health disorders.

Breton JJ, Bergeron L, Valla JP, Berthiaume C, Gaudet N, Lambert J, St-Georges M, Houde L, Lépine S.

J Child Psychol Psychiatry. 1999 Mar;40(3):375-84.

PMID:
10190339
17.

The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity.

Conners CK, Sitarenios G, Parker JD, Epstein JN.

J Abnorm Child Psychol. 1998 Aug;26(4):257-68.

PMID:
9700518
18.

Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.

Spencer T, Biederman J, Wilens T, Steingard R, Geist D.

J Am Acad Child Adolesc Psychiatry. 1993 Jan;32(1):205-10.

PMID:
8428873
19.

Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity.

Szatmari P, Offord DR, Boyle MH.

J Child Psychol Psychiatry. 1989 Mar;30(2):219-30.

PMID:
2708462
20.

Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.

Heishman SJ, Henningfield JE.

Psychopharmacology (Berl). 1991;103(4):436-42.

PMID:
2062984

Supplemental Content

Support Center